Squamous cell carcinoma of the oral cavity in a woman with a 9-year history of ovarian cancer: is exposure to pegylated liposomal Doxorubicin a factor?

This paper reports the case of a platinum-sensitive patient who developed moderately differentiated squamous cell carcinoma of the oral cavity after exposure to pegylated liposomal doxorubicin (PLD). The authors conclude that identification of patients at major risk of PLD-related secondary malignancies and strategies for early detection and reduction of oral carcinogenesis are priorities for future study.